Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1280, 2001-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
EMEA statement on Vioxx withdrawal
Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. :
Access to resources
Recommend
The US Public Citizen group has requested that the FDA remove leflunomide [`Arava']
Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. :
UK CSM issues statement on SSRI use
Reactions Weekly, Vol. 1, Iss. 1031, 2004-01 ,pp. :
EMA's public statement on the use of thujone-containing products
Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. :
Leflunomide and malononitriloamides
By Silva H.T.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 1, 1997-01 ,pp. :